KalVista Pharmaceuticals (KALV) Return on Capital Employed Growth (3y) (2020 - 2025)
KalVista Pharmaceuticals (KALV) Return on Capital Employed Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4,893.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2,416.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,782.00 |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -4,838.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -4,838.00 |
| Apr 30, 2025 | -3,739.00 |
| Oct 31, 2024 | -7,780.00 |
| Jul 31, 2024 | -5,514.00 |
| Apr 30, 2024 | -5,612.00 |
| Jan 31, 2024 | -3,944.00 |
| Oct 31, 2023 | -1,944.00 |
| Jul 31, 2023 | -1,516.00 |
| Apr 30, 2023 | -1,715.00 |
| Jan 31, 2023 | -1,794.00 |
| Oct 31, 2022 | -3,069.00 |
| Jul 31, 2022 | -2,557.00 |
| Apr 30, 2022 | -1,902.00 |
| Jan 31, 2022 | -1,963.00 |
| Oct 31, 2021 | -467.00 |
| Jul 31, 2021 | 3,088.00 |
| Apr 30, 2021 | 948.00 |
| Jan 31, 2021 | 229.00 |
| Oct 31, 2020 | 1,435.00 |
| Jul 31, 2020 | 2,201.00 |